198 related articles for article (PubMed ID: 34094915)
1. Sharp Downregulation of Hub Genes Associated With the Pathogenesis of Breast Cancer From Ductal Carcinoma
Wang Y; Liang F; Zhou Y; Qiu J; Lv Q; Du Z
Front Oncol; 2021; 11():634569. PubMed ID: 34094915
[TBL] [Abstract][Full Text] [Related]
2. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
[TBL] [Abstract][Full Text] [Related]
3. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
4. p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.
Mao XY; Fan CF; Zheng HC; Wei J; Yao F; Jin F
J Exp Clin Cancer Res; 2010 Aug; 29(1):112. PubMed ID: 20712900
[TBL] [Abstract][Full Text] [Related]
5. Weighted gene co-expression network analysis reveals modules and hub genes associated with the development of breast cancer.
Qiu J; Du Z; Wang Y; Zhou Y; Zhang Y; Xie Y; Lv Q
Medicine (Baltimore); 2019 Feb; 98(6):e14345. PubMed ID: 30732163
[TBL] [Abstract][Full Text] [Related]
6. P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma.
Shamloula MM; El-Shorbagy SH; Saied EM
J Egypt Natl Canc Inst; 2007 Sep; 19(3):202-10. PubMed ID: 19190693
[TBL] [Abstract][Full Text] [Related]
7. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3ζ promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression.
Wan D; Zhang Y; Yu Q; Li F; Zhuo J
Pathol Res Pract; 2021 Nov; 227():153619. PubMed ID: 34560418
[TBL] [Abstract][Full Text] [Related]
9. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.
Qi L; Bart J; Tan LP; Platteel I; Sluis Tv; Huitema S; Harms G; Fu L; Hollema H; Berg Av
BMC Cancer; 2009 May; 9():163. PubMed ID: 19473551
[TBL] [Abstract][Full Text] [Related]
10. Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?
Kothari C; Clemenceau A; Ouellette G; Ennour-Idrissi K; Michaud A; Diorio C; Durocher F
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917306
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer.
Fang WB; Medrano M; Cote P; Portsche M; Rao V; Hong Y; Behbod F; Knapp JR; Bloomer C; Noel-Macdonnell J; Cheng N
Front Oncol; 2023; 13():1130911. PubMed ID: 37091166
[TBL] [Abstract][Full Text] [Related]
12. Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.
Moelans CB; de Weger RA; Monsuur HN; Maes AH; van Diest PJ
Anal Cell Pathol (Amst); 2010; 33(3):165-73. PubMed ID: 20978320
[TBL] [Abstract][Full Text] [Related]
13. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M
Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588
[TBL] [Abstract][Full Text] [Related]
14. Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Kim SY; Jung SH; Kim MS; Baek IP; Lee SH; Kim TM; Chung YJ; Lee SH
Oncotarget; 2015 Apr; 6(10):7597-607. PubMed ID: 25831047
[TBL] [Abstract][Full Text] [Related]
15. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
16. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Moelans CB; Verschuur-Maes AH; van Diest PJ
J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the breast ductal carcinoma in situ signature and its prognostic implications.
Zhang J; Lin H; Hou L; Xiao H; Gong X; Guo X; Cao X; Liu Z
Cancer Med; 2023 Feb; 12(3):3758-3772. PubMed ID: 35880695
[TBL] [Abstract][Full Text] [Related]
18. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.
Zagouri F; Sergentanis TN; Nonni A; Papadimitriou CA; Michalopoulos NV; Domeyer P; Theodoropoulos G; Lazaris A; Patsouris E; Zogafos E; Pazaiti A; Zografos GC
BMC Cancer; 2010 Jul; 10():353. PubMed ID: 20602789
[TBL] [Abstract][Full Text] [Related]
20. Parity Differently Affects the Breast Cancer Specific Survival from Ductal Carcinoma In Situ to Invasive Cancer: A Registry-Based Retrospective Study from Korea.
Lee J; Oh M; Ko S; Park C; Lee ES; Kim HA; Jung Y; Lee J;
Breast Cancer (Auckl); 2019; 13():1178223418825134. PubMed ID: 30728717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
